© 2001 American Heart Association, Inc.
Integrative Physiology |
Absence of CD40 Signaling Is Associated With an Increase in Intimal Thickening After Arterial Injury
From the Division of Cardiology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, Calif.
Correspondence to Bojan Cercek, MD, PhD, Division of Cardiology, Room 5314, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail cercek{at}cshs.org
Abstract—Immune-mediator CD40 ligand is expressed on a variety of cell types involved in the immune response and on the cells of the vascular system. Inhibition of CD40 signaling has been associated with reduction of experimental atherosclerosis and transplant-associated vasculopathy. Immune response also plays a cardinal role in intimal thickening after acute arterial-wall injury. After carotid artery injury in CD40 ligand knockout (CD40L-/-) mice, the intimal thickening was increased 3-fold compared with the thickening in background B6/129 mice. The extent of thickening was similar to the thickening in B6/129 mice depleted of T lymphocytes with anti-CD4 and anti-CD8 antibodies. Injection of splenocytes from B6/129 mice into the CD40L-/- mice reduced the intimal thickening to the level comparable to the thickening in background B6/129 mice. These data suggest that CD40 signaling plays a significant role in the inhibitory effect of T lymphocytes on intimal thickening after arterial injury.
Key Words: CD40 • CD40 ligand • T lymphocytes • intimal thickening • arterial wall injury
This article has been cited by other articles:
 |
|
 |
|
  J.-i. Abe and C.-H. Woo NADPH Oxidase in Vascular Injury: A New Insight About Its Regulation and Role in T Cells Circ. Res., January 30, 2009; 104(2): 147 - 149. [Full Text] [PDF]
|
|
|
|
|
|
J. B.K. Schwarz, N. Langwieser, N. N. Langwieser, M. J. Bek, S. Seidl, H.-H. Eckstein, B. Lu, A. Schomig, H. Pavenstadt, and D. Zohlnhofer Novel Role of the CXC Chemokine Receptor 3 in Inflammatory Response to Arterial Injury: Involvement of mTORC1 Circ. Res., January 30, 2009; 104(2): 189 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Malinin and T. Byzova CD40/TRAF6 switch in neointimal hyperplasia Blood, May 1, 2008; 111(9): 4424 - 4424. [Full Text] [PDF]
|
|
|
|
|
|
M. M. P. C. Donners, L. Beckers, D. Lievens, I. Munnix, J. Heemskerk, B. J. Janssen, E. Wijnands, J. Cleutjens, A. Zernecke, C. Weber, et al. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling Blood, May 1, 2008; 111(9): 4596 - 4604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Strom, M. Wigren, A. Hultgardh-Nilsson, A. Saxena, M. F. Gomez, S. Cardell, G. N. Fredrikson, and J. Nilsson Involvement of the CD1d Natural Killer T Cell Pathway in Neointima Formation After Vascular Injury Circ. Res., October 12, 2007; 101(8): e83 - e89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xing, A. Miller, L. Novak, R. Rocha, Y.-F. Chen, and S. Oparil Estradiol and Progestins Differentially Modulate Leukocyte Infiltration After Vascular Injury Circulation, January 20, 2004; 109(2): 234 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matetzky, M. Domingo, S. Kar, M. Noc, P. K. Shah, S. Kaul, E. Daar, and B. Cercek Acute Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients Arch Intern Med, February 24, 2003; 163(4): 457 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson, J. Yano, P. K. Shah, S. Jovinge, and J. Nilsson Inhibitory Effect on Arterial Injury-Induced Neointimal Formation by Adoptive B-Cell Transfer in Rag-1 Knockout Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 644 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson, J. Yano, P. K. Shah, S. Jovinge, and J. Nilsson Inhibitory Effect on Arterial Injury-Induced Neointimal Formation by Adoptive B-Cell Transfer in Rag-1 Knockout Mice Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 644 - 649. [Abstract] [Full Text] [PDF]
|
|